Job overview
The post holder will play a key role in an internationally recognised team contributing to global TB vaccine and drug initiatives. The team are responsible for the delivery of the scientific and technical activities associated with the use of advanced in vivo models of M. tuberculosis infection for the evaluation of novel TB vaccine strategies and therapeutics
Main duties of the job
Research & Evaluation department, based at UKHSA Porton, is the UK’s largest capability for the handling of dangerous human pathogens and animalmodelling of infectious diseases. The capability is used to understand pathogenesis and undertake pre-clinical development and assessment of new vaccines and therapeutics. The capability is also used to undertake studies in microbiological aerobiology, decontamination and detection, and to develop diagnostic assays for clinical use. Studies are focussed on high priority activities including: SARS-CoV-2, Ebola, Zika, Crimean Congo Haemorrhagic Fever, Q Fever, Anthrax, Melioidosis, Clostridium difficile-Associated Disease, Tuberculosis, Monkeypox, Influenza, Pertussis, Meningococcal disease, Group B Streptococcal disease, Legionnaires Disease, Healthcare Acquired Infections, Anti-Microbial Resistance, etc.
The capability is available to UK government in the event of a microbiological emergency, as has been demonstrated during the West Africa Ebola outbreak, where Research & Evaluation staff were deployed to Sierra Leone, Guinea and Liberia.’
Find out more and apply online.
